Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2025(Status and Outlook)

January 2025 | 171 pages | ID: GEB19ECE1156EN
Bosson Research

Abstracts

Report Overview

Antidiabetic SGLT-2 inhibitors are a class of oral medications used to treat type 2 diabetes by blocking the sodium-glucose transport protein 2 in the kidneys, thereby reducing glucose reabsorption and increasing glucose excretion in the urine. This mechanism helps lower blood sugar levels in diabetic patients. SGLT-2 inhibitors are typically prescribed in conjunction with diet and exercise to improve glycemic control. They have gained popularity in recent years as an effective treatment option for type 2 diabetes due to their ability to lower blood sugar levels, promote weight loss, and reduce the risk of cardiovascular events in diabetic patients.

The market for antidiabetic SGLT-2 inhibitors has been experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing prevalence of type 2 diabetes globally, fueled by factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates. As the diabetic population continues to grow, there is a growing demand for effective and innovative treatment options like SGLT-2 inhibitors. Additionally, the emphasis on early diagnosis and treatment of diabetes by healthcare providers is driving the adoption of SGLT-2 inhibitors as a first-line treatment option due to their proven efficacy and safety profile.

Furthermore, the market trend for antidiabetic SGLT-2 inhibitors is also influenced by ongoing research and development activities aimed at expanding their indications and improving their efficacy and safety profiles. Pharmaceutical companies are investing in clinical trials to explore the potential benefits of SGLT-2 inhibitors in treating other conditions such as heart failure and chronic kidney disease, which presents significant growth opportunities in the market. Additionally, the introduction of new SGLT-2 inhibitors with improved formulations and dosing regimens is expected to further drive market growth in the coming years.

This report provides a deep insight into the global Antidiabetic SGLT-2 Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antidiabetic SGLT-2 Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antidiabetic SGLT-2 Inhibitor market in any manner.

Global Antidiabetic SGLT-2 Inhibitor Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

AstraZeneca

Johnson & Johnson

GlaxoSmithKline

Merck & Co

Eli Lilly

Sanofi

Takeda Pharmaceuticals

Novo Nordisk

Servier Laboratories

Boehringer Ingelheim

Bristol-Myers Squibb

Market Segmentation (by Type)

Canagliflozin

Empagliflozin

Dapagliflozin

Other

Market Segmentation (by Application)

Hospitals

Clinics

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Antidiabetic SGLT-2 Inhibitor Market
• Overview of the regional outlook of the Antidiabetic SGLT-2 Inhibitor Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antidiabetic SGLT-2 Inhibitor Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Antidiabetic SGLT-2 Inhibitor
1.2 Key Market Segments
  1.2.1 Antidiabetic SGLT-2 Inhibitor Segment by Type
  1.2.2 Antidiabetic SGLT-2 Inhibitor Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTIDIABETIC SGLT-2 INHIBITOR MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Antidiabetic SGLT-2 Inhibitor Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTIDIABETIC SGLT-2 INHIBITOR MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Antidiabetic SGLT-2 Inhibitor Product Life Cycle
3.3 Global Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2020-2025)
3.4 Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Manufacturers (2020-2025)
3.5 Antidiabetic SGLT-2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antidiabetic SGLT-2 Inhibitor Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Antidiabetic SGLT-2 Inhibitor Sales Sites, Area Served, Product Type
3.8 Antidiabetic SGLT-2 Inhibitor Market Competitive Situation and Trends
  3.8.1 Antidiabetic SGLT-2 Inhibitor Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Antidiabetic SGLT-2 Inhibitor Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ANTIDIABETIC SGLT-2 INHIBITOR INDUSTRY CHAIN ANALYSIS

4.1 Antidiabetic SGLT-2 Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTIDIABETIC SGLT-2 INHIBITOR MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
  5.6.1 Industry Policies Analysis
  5.6.2 Economic Environment Analysis
  5.6.3 Social Environment Analysis
  5.6.4 Technological Environment Analysis
5.7 Global Antidiabetic SGLT-2 Inhibitor Market Porter's Five Forces Analysis
  5.7.1 Global Trade Frictions
  5.7.2 Global Trade Frictions and Their Impacts to Antidiabetic SGLT-2 Inhibitor Market
5.8 ESG Ratings of Leading Companies

6 ANTIDIABETIC SGLT-2 INHIBITOR MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2020-2025)
6.3 Global Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Type (2020-2025)
6.4 Global Antidiabetic SGLT-2 Inhibitor Price by Type (2020-2025)

7 ANTIDIABETIC SGLT-2 INHIBITOR MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antidiabetic SGLT-2 Inhibitor Market Sales by Application (2020-2025)
7.3 Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD) by Application (2020-2025)
7.4 Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2020-2025)

8 ANTIDIABETIC SGLT-2 INHIBITOR MARKET SALES BY REGION

8.1 Global Antidiabetic SGLT-2 Inhibitor Sales by Region
  8.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales by Region
  8.1.2 Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region
8.2 Global Antidiabetic SGLT-2 Inhibitor Market Size by Region
  8.2.1 Global Antidiabetic SGLT-2 Inhibitor Market Size by Region
  8.2.2 Global Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Region
8.3 North America
  8.3.1 North America Antidiabetic SGLT-2 Inhibitor Sales by Country
  8.3.2 North America Antidiabetic SGLT-2 Inhibitor Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Antidiabetic SGLT-2 Inhibitor Sales by Country
  8.4.2 Europe Antidiabetic SGLT-2 Inhibitor Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Antidiabetic SGLT-2 Inhibitor Sales by Region
  8.5.2 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Antidiabetic SGLT-2 Inhibitor Sales by Country
  8.6.2 South America Antidiabetic SGLT-2 Inhibitor Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Antidiabetic SGLT-2 Inhibitor Sales by Region
  8.7.2 Middle East and Africa Antidiabetic SGLT-2 Inhibitor Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ANTIDIABETIC SGLT-2 INHIBITOR MARKET PRODUCTION BY REGION

9.1 Global Production of Antidiabetic SGLT-2 Inhibitor by Region(2020-2025)
9.2 Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region (2020-2025)
9.3 Global Antidiabetic SGLT-2 Inhibitor Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antidiabetic SGLT-2 Inhibitor Production
  9.4.1 North America Antidiabetic SGLT-2 Inhibitor Production Growth Rate (2020-2025)
  9.4.2 North America Antidiabetic SGLT-2 Inhibitor Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antidiabetic SGLT-2 Inhibitor Production
  9.5.1 Europe Antidiabetic SGLT-2 Inhibitor Production Growth Rate (2020-2025)
  9.5.2 Europe Antidiabetic SGLT-2 Inhibitor Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antidiabetic SGLT-2 Inhibitor Production (2020-2025)
  9.6.1 Japan Antidiabetic SGLT-2 Inhibitor Production Growth Rate (2020-2025)
  9.6.2 Japan Antidiabetic SGLT-2 Inhibitor Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antidiabetic SGLT-2 Inhibitor Production (2020-2025)
  9.7.1 China Antidiabetic SGLT-2 Inhibitor Production Growth Rate (2020-2025)
  9.7.2 China Antidiabetic SGLT-2 Inhibitor Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer
  10.1.1 Pfizer Basic Information
  10.1.2 Pfizer Antidiabetic SGLT-2 Inhibitor Product Overview
  10.1.3 Pfizer Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.1.4 Pfizer Business Overview
  10.1.5 Pfizer SWOT Analysis
  10.1.6 Pfizer Recent Developments
10.2 AstraZeneca
  10.2.1 AstraZeneca Basic Information
  10.2.2 AstraZeneca Antidiabetic SGLT-2 Inhibitor Product Overview
  10.2.3 AstraZeneca Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.2.4 AstraZeneca Business Overview
  10.2.5 AstraZeneca SWOT Analysis
  10.2.6 AstraZeneca Recent Developments
10.3 Johnson and Johnson
  10.3.1 Johnson and Johnson Basic Information
  10.3.2 Johnson and Johnson Antidiabetic SGLT-2 Inhibitor Product Overview
  10.3.3 Johnson and Johnson Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.3.4 Johnson and Johnson Business Overview
  10.3.5 Johnson and Johnson SWOT Analysis
  10.3.6 Johnson and Johnson Recent Developments
10.4 GlaxoSmithKline
  10.4.1 GlaxoSmithKline Basic Information
  10.4.2 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product Overview
  10.4.3 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.4.4 GlaxoSmithKline Business Overview
  10.4.5 GlaxoSmithKline Recent Developments
10.5 Merck and Co
  10.5.1 Merck and Co Basic Information
  10.5.2 Merck and Co Antidiabetic SGLT-2 Inhibitor Product Overview
  10.5.3 Merck and Co Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.5.4 Merck and Co Business Overview
  10.5.5 Merck and Co Recent Developments
10.6 Eli Lilly
  10.6.1 Eli Lilly Basic Information
  10.6.2 Eli Lilly Antidiabetic SGLT-2 Inhibitor Product Overview
  10.6.3 Eli Lilly Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.6.4 Eli Lilly Business Overview
  10.6.5 Eli Lilly Recent Developments
10.7 Sanofi
  10.7.1 Sanofi Basic Information
  10.7.2 Sanofi Antidiabetic SGLT-2 Inhibitor Product Overview
  10.7.3 Sanofi Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.7.4 Sanofi Business Overview
  10.7.5 Sanofi Recent Developments
10.8 Takeda Pharmaceuticals
  10.8.1 Takeda Pharmaceuticals Basic Information
  10.8.2 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product Overview
  10.8.3 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.8.4 Takeda Pharmaceuticals Business Overview
  10.8.5 Takeda Pharmaceuticals Recent Developments
10.9 Novo Nordisk
  10.9.1 Novo Nordisk Basic Information
  10.9.2 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product Overview
  10.9.3 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.9.4 Novo Nordisk Business Overview
  10.9.5 Novo Nordisk Recent Developments
10.10 Servier Laboratories
  10.10.1 Servier Laboratories Basic Information
  10.10.2 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product Overview
  10.10.3 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.10.4 Servier Laboratories Business Overview
  10.10.5 Servier Laboratories Recent Developments
10.11 Boehringer Ingelheim
  10.11.1 Boehringer Ingelheim Basic Information
  10.11.2 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product Overview
  10.11.3 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.11.4 Boehringer Ingelheim Business Overview
  10.11.5 Boehringer Ingelheim Recent Developments
10.12 Bristol-Myers Squibb
  10.12.1 Bristol-Myers Squibb Basic Information
  10.12.2 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product Overview
  10.12.3 Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product Market Performance
  10.12.4 Bristol-Myers Squibb Business Overview
  10.12.5 Bristol-Myers Squibb Recent Developments

11 ANTIDIABETIC SGLT-2 INHIBITOR MARKET FORECAST BY REGION

11.1 Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast
11.2 Global Antidiabetic SGLT-2 Inhibitor Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country
  11.2.3 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Region
  11.2.4 South America Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Antidiabetic SGLT-2 Inhibitor by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Antidiabetic SGLT-2 Inhibitor Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Antidiabetic SGLT-2 Inhibitor by Type (2026-2033)
  12.1.2 Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Antidiabetic SGLT-2 Inhibitor by Type (2026-2033)
12.2 Global Antidiabetic SGLT-2 Inhibitor Market Forecast by Application (2026-2033)
  12.2.1 Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) Forecast by Application
  12.2.2 Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antidiabetic SGLT-2 Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Antidiabetic SGLT-2 Inhibitor Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic SGLT-2 Inhibitor as of 2024)
Table 10. Global Market Antidiabetic SGLT-2 Inhibitor Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Antidiabetic SGLT-2 Inhibitor Sales Sites and Area Served
Table 12. Manufacturers Antidiabetic SGLT-2 Inhibitor Product Type
Table 13. Global Antidiabetic SGLT-2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Antidiabetic SGLT-2 Inhibitor Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Antidiabetic SGLT-2 Inhibitor Sales by Type (K MT)
Table 25. Global Antidiabetic SGLT-2 Inhibitor Market Size by Type (M USD)
Table 26. Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) by Type (2020-2025)
Table 27. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Type (2020-2025)
Table 28. Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD) by Type (2020-2025)
Table 29. Global Antidiabetic SGLT-2 Inhibitor Market Size Share by Type (2020-2025)
Table 30. Global Antidiabetic SGLT-2 Inhibitor Price (USD/MT) by Type (2020-2025)
Table 31. Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) by Application
Table 32. Global Antidiabetic SGLT-2 Inhibitor Market Size by Application
Table 33. Global Antidiabetic SGLT-2 Inhibitor Sales by Application (2020-2025) & (K MT)
Table 34. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2020-2025)
Table 35. Global Antidiabetic SGLT-2 Inhibitor Market Size by Application (2020-2025) & (M USD)
Table 36. Global Antidiabetic SGLT-2 Inhibitor Market Share by Application (2020-2025)
Table 37. Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2020-2025)
Table 38. Global Antidiabetic SGLT-2 Inhibitor Sales by Region (2020-2025) & (K MT)
Table 39. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2020-2025)
Table 40. Global Antidiabetic SGLT-2 Inhibitor Market Size by Region (2020-2025) & (M USD)
Table 41. Global Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Region (2020-2025)
Table 42. North America Antidiabetic SGLT-2 Inhibitor Sales by Country (2020-2025) & (K MT)
Table 43. North America Antidiabetic SGLT-2 Inhibitor Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Antidiabetic SGLT-2 Inhibitor Sales by Country (2020-2025) & (K MT)
Table 45. Europe Antidiabetic SGLT-2 Inhibitor Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Antidiabetic SGLT-2 Inhibitor Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Antidiabetic SGLT-2 Inhibitor Market Size by Region (2020-2025) & (M USD)
Table 48. South America Antidiabetic SGLT-2 Inhibitor Sales by Country (2020-2025) & (K MT)
Table 49. South America Antidiabetic SGLT-2 Inhibitor Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Market Size by Region (2020-2025) & (M USD)
Table 52. Global Antidiabetic SGLT-2 Inhibitor Production (K MT) by Region(2020-2025)
Table 53. Global Antidiabetic SGLT-2 Inhibitor Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region (2020-2025)
Table 55. Global Antidiabetic SGLT-2 Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Antidiabetic SGLT-2 Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Antidiabetic SGLT-2 Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Antidiabetic SGLT-2 Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Antidiabetic SGLT-2 Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Pfizer Basic Information
Table 61. Pfizer Antidiabetic SGLT-2 Inhibitor Product Overview
Table 62. Pfizer Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Pfizer Business Overview
Table 64. Pfizer SWOT Analysis
Table 65. Pfizer Recent Developments
Table 66. AstraZeneca Basic Information
Table 67. AstraZeneca Antidiabetic SGLT-2 Inhibitor Product Overview
Table 68. AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca SWOT Analysis
Table 71. AstraZeneca Recent Developments
Table 72. Johnson and Johnson Basic Information
Table 73. Johnson and Johnson Antidiabetic SGLT-2 Inhibitor Product Overview
Table 74. Johnson and Johnson Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Johnson and Johnson Business Overview
Table 76. Johnson and Johnson SWOT Analysis
Table 77. Johnson and Johnson Recent Developments
Table 78. GlaxoSmithKline Basic Information
Table 79. GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Product Overview
Table 80. GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Recent Developments
Table 83. Merck and Co Basic Information
Table 84. Merck and Co Antidiabetic SGLT-2 Inhibitor Product Overview
Table 85. Merck and Co Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Merck and Co Business Overview
Table 87. Merck and Co Recent Developments
Table 88. Eli Lilly Basic Information
Table 89. Eli Lilly Antidiabetic SGLT-2 Inhibitor Product Overview
Table 90. Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Recent Developments
Table 93. Sanofi Basic Information
Table 94. Sanofi Antidiabetic SGLT-2 Inhibitor Product Overview
Table 95. Sanofi Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Sanofi Business Overview
Table 97. Sanofi Recent Developments
Table 98. Takeda Pharmaceuticals Basic Information
Table 99. Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Product Overview
Table 100. Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Takeda Pharmaceuticals Business Overview
Table 102. Takeda Pharmaceuticals Recent Developments
Table 103. Novo Nordisk Basic Information
Table 104. Novo Nordisk Antidiabetic SGLT-2 Inhibitor Product Overview
Table 105. Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Recent Developments
Table 108. Servier Laboratories Basic Information
Table 109. Servier Laboratories Antidiabetic SGLT-2 Inhibitor Product Overview
Table 110. Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Servier Laboratories Business Overview
Table 112. Servier Laboratories Recent Developments
Table 113. Boehringer Ingelheim Basic Information
Table 114. Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Product Overview
Table 115. Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Boehringer Ingelheim Business Overview
Table 117. Boehringer Ingelheim Recent Developments
Table 118. Bristol-Myers Squibb Basic Information
Table 119. Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Product Overview
Table 120. Bristol-Myers Squibb Antidiabetic SGLT-2 Inhibitor Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Recent Developments
Table 123. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Region (2026-2033) & (K MT)
Table 124. Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Region (2026-2033) & (M USD)
Table 125. North America Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2026-2033) & (K MT)
Table 126. North America Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country (2026-2033) & (M USD)
Table 127. Europe Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2026-2033) & (K MT)
Table 128. Europe Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Asia Pacific Antidiabetic SGLT-2 Inhibitor Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Asia Pacific Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. South America Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2026-2033) & (K MT)
Table 132. South America Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Sales Forecast by Country (2026-2033) & (Units)
Table 134. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Type (2026-2033) & (K MT)
Table 136. Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Type (2026-2033) & (M USD)
Table 137. Global Antidiabetic SGLT-2 Inhibitor Price Forecast by Type (2026-2033) & (USD/MT)
Table 138. Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) Forecast by Application (2026-2033)
Table 139. Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Antidiabetic SGLT-2 Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD), 2024-2033
Figure 5. Global Antidiabetic SGLT-2 Inhibitor Market Size (M USD) (2020-2033)
Figure 6. Global Antidiabetic SGLT-2 Inhibitor Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antidiabetic SGLT-2 Inhibitor Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antidiabetic SGLT-2 Inhibitor Product Life Cycle
Figure 13. Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers in 2024
Figure 14. Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers in 2024
Figure 15. Antidiabetic SGLT-2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Antidiabetic SGLT-2 Inhibitor Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antidiabetic SGLT-2 Inhibitor Revenue in 2024
Figure 18. Industry Chain Map of Antidiabetic SGLT-2 Inhibitor
Figure 19. Global Antidiabetic SGLT-2 Inhibitor Market PESTE Analysis
Figure 20. Global Antidiabetic SGLT-2 Inhibitor Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antidiabetic SGLT-2 Inhibitor Market Share by Type
Figure 27. Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2020-2025)
Figure 28. Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type in 2024
Figure 29. Market Size Share of Antidiabetic SGLT-2 Inhibitor by Type (2020-2025)
Figure 30. Market Size Share of Antidiabetic SGLT-2 Inhibitor by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antidiabetic SGLT-2 Inhibitor Market Share by Application
Figure 33. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2020-2025)
Figure 34. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application in 2024
Figure 35. Global Antidiabetic SGLT-2 Inhibitor Market Share by Application (2020-2025)
Figure 36. Global Antidiabetic SGLT-2 Inhibitor Market Share by Application in 2024
Figure 37. Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2020-2025)
Figure 39. Global Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Region (2020-2025)
Figure 40. North America Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2024
Figure 43. North America Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Country in 2024
Figure 45. U.S. Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antidiabetic SGLT-2 Inhibitor Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antidiabetic SGLT-2 Inhibitor Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antidiabetic SGLT-2 Inhibitor Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antidiabetic SGLT-2 Inhibitor Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2024
Figure 53. Europe Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Country in 2024
Figure 55. Germany Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Region in 2024
Figure 68. China Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (K MT)
Figure 79. South America Antidiabetic SGLT-2 Inhibitor Sales Market Share by Country in 2024
Figure 80. South America Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (M USD)
Figure 81. South America Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Country in 2024
Figure 82. Brazil Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antidiabetic SGLT-2 Inhibitor Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antidiabetic SGLT-2 Inhibitor Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antidiabetic SGLT-2 Inhibitor Production Market Share by Region (2020-2025)
Figure 103. North America Antidiabetic SGLT-2 Inhibitor Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antidiabetic SGLT-2 Inhibitor Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antidiabetic SGLT-2 Inhibitor Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antidiabetic SGLT-2 Inhibitor Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Antidiabetic SGLT-2 Inhibitor Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Antidiabetic SGLT-2 Inhibitor Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Antidiabetic SGLT-2 Inhibitor Market Share Forecast by Type (2026-2033)
Figure 111. Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Application (2026-2033)
Figure 112. Global Antidiabetic SGLT-2 Inhibitor Market Share Forecast by Application (2026-2033)